| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 08/21/2002 | EP1231939A2 Oncolytic combinations for the treatment of cancer |
| 08/21/2002 | EP1153020A4 Production of isoflavone derivatives |
| 08/21/2002 | CN1364760A New process for extracting high purity puerarin by pure water method |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/20/2002 | US6436987 Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid |
| 08/20/2002 | US6436986 Administering dibenzopyran's as preferential hyperglycemic, dietetic or hypertriglyceridemic agents |
| 08/20/2002 | CA2219648C Derivatives of 6,8-difluoro-7-hydroxycoumarin |
| 08/20/2002 | CA2203463C New diosmetin acids and esters, and the pharmaceutical compounds that contain them |
| 08/15/2002 | WO2002062782A1 Method for the production of dronabinol |
| 08/15/2002 | WO2002062781A1 Preparation of isocoumarin derivatives and intermediates for the synthesis thereof |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002062333A1 Use of 9h-xanthenes in a method of inhibiting viral replication targeting the nucleocapsid protein |
| 08/15/2002 | WO2002062324A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | WO2002062293A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/15/2002 | US20020111466 Isoflavone for use in treatment of cancer, osteoporosis and autoimmune diseases; for use in nutrients |
| 08/15/2002 | US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/15/2002 | US20020110874 Recombinant production of novel polyketides |
| 08/15/2002 | CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | CA2436735A1 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/14/2002 | EP1230234A1 Naphthopyrans annelated in c5-c6 with an indene-or dihydronaphthalene-type ring and compositions and matrices containing them |
| 08/14/2002 | EP1230233A1 5-halo-4-fluoro-4,7,7-trimethyl-3-oxabicyclo 4.1.0]heptane-2-ones, method for their production and their use in the production of cyclopropane carboxylic acids |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2002 | EP0814823B1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | DE10104350A1 Verfahren zur Herstellung von Flavon Derivaten A process for producing flavone derivatives |
| 08/14/2002 | CN1364082A Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having same effective composition |
| 08/14/2002 | CN1089092C Deterpene-kind compound anticancer drug capable of promoting differentiation and depressing proliferation and preparation method and use thereof |
| 08/14/2002 | CN1089091C Method for extracting folium crataegi total flavone |
| 08/13/2002 | CA2207360C Recovery of isoflavones from soy molasses |
| 08/08/2002 | WO2002060889A1 Method for producing flavone derivatives |
| 08/08/2002 | WO2002060888A1 Processes for preparing chromanylbenzoic acids |
| 08/08/2002 | WO2002060887A2 Synthesis of 4h-chromene derivatives |
| 08/08/2002 | WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | WO2002012542A3 Enzyme substrate |
| 08/08/2002 | WO2001094335A3 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
| 08/08/2002 | US20020107411 Such as 25-hydroxy-3-aminopropoxyvitamin D3 biotinamide; kits |
| 08/08/2002 | US20020107406 Calcium receptor-active compounds |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107207 2,5,7,8-tetramethyl-2R-(4,8,12-trimethyl-3,7,11 E:Z tridecatrien)chroman-6-yloxy) acetic acid for example; use as antiproliferative agent |
| 08/08/2002 | US20020106338 Galenical formulation |
| 08/08/2002 | CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | CA2433516A1 Processes for preparing chromanylbenzoic acids |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/07/2002 | EP1229036A1 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 08/07/2002 | EP1228058A1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 08/07/2002 | EP1227791A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 08/07/2002 | EP0983259B1 Tocopherol esters and their cosmetic and pharmaceutical uses |
| 08/07/2002 | EP0971695A4 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 08/07/2002 | CN1362951A Dihetero-substituted metalloprotease inhibitors |
| 08/07/2002 | CN1362882A Use of catechin for preventing or treaitng coronary restenosts |
| 08/07/2002 | CN1362252A Method of eliminating gingkolic acid from gingko extract |
| 08/07/2002 | CN1088855C Oximesulfonic acid esters and use thereof as latent sulfonic acids |
| 08/06/2002 | US6429320 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures |
| 08/01/2002 | WO2002059113A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 08/01/2002 | WO2002059103A1 Synthesis of beta-lapachone and its intermediates |
| 08/01/2002 | WO2002058694A2 Method of treating hematologic tumors and cancers using beta lapachone |
| 08/01/2002 | WO2002036832A3 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 08/01/2002 | WO2002005794A3 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 08/01/2002 | US20020103389 Klainetins and their derivatives, method for their preparation and use thereof |
| 08/01/2002 | US20020103242 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
| 08/01/2002 | CA2435775A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 08/01/2002 | CA2428425A1 Method of treating hematologic tumors and cancers |
| 07/31/2002 | EP1227104A1 Processes for producing and purifying aspartame derivatives and process for producing production intermediates |
| 07/31/2002 | EP1227089A1 Manufacture of (all-rac)-alpha-Tocopherol |
| 07/31/2002 | EP1226134A2 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them |
| 07/31/2002 | EP1225878A1 Treatment of emphysema using rar selective retinold agonists |
| 07/31/2002 | CN1360890A Use of active retiene derivative with negative hormone and/or antagonist |
| 07/31/2002 | CN1088457C Photochromic naphthopyran compounds |
| 07/30/2002 | US6426420 Process for producing isocoumarines and intermediates for the same |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002056700A2 Process for obtaining solid soy isoflavone-containing products |
| 07/25/2002 | WO2002039960A3 Cosmetic method of treating skin |
| 07/25/2002 | WO2002015884A3 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2001040188A9 Curcumin analogues for treating cancer |
| 07/25/2002 | US20020099227 Processesand intermediatesfor preparing substitutedchromanol derivatives |
| 07/25/2002 | US20020099095 For treatment and prophylactic treatment of ageing of the skin, for pretreatment or after-treatment of hair or scalp or of the hair root region, in particular before or after hair treatment, for example during colouring |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099056 Used for treatment of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders neuroleptic agents. |
| 07/25/2002 | US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/24/2002 | EP1223928A2 Use of flavones, coumarins and related compounds to treat infections |
| 07/24/2002 | EP1223808A1 Peripheral cannabinoid receptor (cb2) selective ligands |
| 07/24/2002 | EP0889041B1 Novel iridoid derivatives and neovascularization inhibitors containing the same as active ingredient |
| 07/24/2002 | EP0885230B1 Camptothecin derivatives and the use thereof as antitumor agents |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | CN1088066C Process for producing chromans |
| 07/23/2002 | US6423851 From trimethylhydroquinone and isophytol using catalyst |
| 07/23/2002 | US6423747 Cosmetic and dermatological preparations with flavonoids |
| 07/23/2002 | US6423744 Administering an amount of a leukotriene b4 (ltb4) antagonist, preferably a ltb4 receptor antagonistic, to a patient exhibiting adverse drug effect due to exogenous interleukin-2, to decrease the adverse effects |
| 07/23/2002 | US6423743 Analyzing for gene for expression of procyanidin |
| 07/23/2002 | US6423365 Mixture of anthocyanins, bioflavonoids and phenols from cherries with bulking agent, washing and separation |
| 07/18/2002 | WO2002055522A2 Novel multi-ring organic compounds for regulating gut motility and food intake |
| 07/18/2002 | WO2002055512A1 Xanthene derivatives |
| 07/18/2002 | WO2002055014A2 Therapeutic chroman compounds |
| 07/18/2002 | WO2002055013A2 Therapeutic chromone compounds |
| 07/18/2002 | WO2002055012A2 Therapeutic heterocyclic compounds |
| 07/18/2002 | WO2001093690A3 An improved method for extracting cocoa procyanidins |